SCHEMBL4435700

SCHEMBL4435700

CON=CC(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
HCAR2 Q8TDS4 2/20 0.56
ALDH1A1 P00352 6/20 0.53
CA12 O43570 2/20 0.53
CA4 P22748 2/20 0.53
CA6 P23280 2/20 0.53
CA5A P35218 2/20 0.53
CA7 P43166 2/20 0.53
CA9 Q16790 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA5B Q9Y2D0 2/20 0.53
AKR1B10 O60218 2/20 0.53
AKR1B1 P15121 2/20 0.53
TTR P02766 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664501 0.78 HCAR2 (0.57) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL3127108 0.78 LMNA (0.46) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL10367878 0.77 HCAR2 (0.61) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL219575 0.77 HCAR2 (0.65) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL3664499 0.77 HCAR2 (0.56) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL16631728 0.77 ALDH1A1 (0.46) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL3664497 0.77 HCAR2 (0.56) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL337503 0.76 HCAR2 (0.89) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL9395526 0.76 HCAR2 (0.69) LMNAHCAR2ALDH1A1CA12CA4
SCHEMBL357565 0.76 HCAR2 (0.89) LMNAHCAR2ALDH1A1CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012466-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-01-10 US disclosed
US-8232254-B2 Colchicine glycosylated to include a sugar moiety on a methoxyamino-appended colchicine; cytolysis equivalent to paclitaxel and doxorubicin; stabilizers of tubulin formation; anticarcinogenic -arthritic agents; Mediterranean fever, amyloidosis, scleroderma, irritable bowel syndrome or gout WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-07-31 US disclosed
EP-2076525-A2 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE Wisconsin Alumni Research Foundation (US) 2009-07-08 EP disclosed
WO-2008067039-A9 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RES FOUND (US) 2008-10-16 WO disclosed
US-20080171787-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-07-17 US disclosed
WO-2008067039-A2 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171787-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE TUBB6, TUBB, TUBA1C LMNA 1662/4885HCAR2 3353/4885ALDH1A1 3136/4885
US-20130012466-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE TUBB6, TUBB, TUBA1C LMNA 1662/4885HCAR2 3353/4885ALDH1A1 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.